Abbott (ABT) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

Abbott Laboratories failed to shed a proposed class action alleging it duped consumers into thinking its PediaSure Grow & ...

By Jonathan Stempel NEW YORK, June 4 (Reuters) - Abbott Laboratories must defend against a proposed class-action lawsuit ...

Matt Powers, Powers Advisory Group, joins 'Power Lunch' to discuss how investors can counterbalance their AI exposure.

Abbott Laboratories (NYSE:ABT) is one of the best healthcare stocks to buy with highest upside potential. Abbott Laboratories ...

Abbott Laboratories (ABT) is back in focus after mixed first quarter results, a cut to its 2026 adjusted EPS outlook tied to ...

A Missouri appellate court has upheld a $495 million verdict against Abbott Laboratories in a case over whether its formula for premature infants caused a girl to become seriously ill.

Abbott Laboratories must pay $53 million in compensatory damages in four cases in which Chicago area babies developed a dangerous intestinal disease after consuming the company’s formula for premature ...

A former senior district sales manager for an Abbott Laboratories Inc. subsidiary says the company violated the False Claims ...

View Abbott Laboratories ABT stock quote prices, financial information, real-time forecasts, and company news from CNN.

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...